413 related articles for article (PubMed ID: 29037975)
1. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Hit Screening Cascade to Identify Respiratory Syncytial Virus (RSV) Inhibitors.
Plant H; Stacey C; Tiong-Yip CL; Walsh J; Yu Q; Rich K
J Biomol Screen; 2015 Jun; 20(5):597-605. PubMed ID: 25656237
[TBL] [Abstract][Full Text] [Related]
4. A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs).
Gobel J; Gartland M; Gurley SH; Kadwell S; Gillie D; Moore C; Goetz A
J Biomol Screen; 2015 Jul; 20(6):729-38. PubMed ID: 25862685
[TBL] [Abstract][Full Text] [Related]
5. High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.
Patel DA; Patel AC; Nolan WC; Zhang Y; Holtzman MJ
PLoS One; 2012; 7(5):e36594. PubMed ID: 22574190
[TBL] [Abstract][Full Text] [Related]
6. Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.
Cui R; Wang Y; Wang L; Li G; Lan K; Altmeyer R; Zou G
Antiviral Res; 2016 Aug; 132():38-45. PubMed ID: 27210812
[TBL] [Abstract][Full Text] [Related]
7. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.
Young DF; Didcock L; Goodbourn S; Randall RE
Virology; 2000 Apr; 269(2):383-90. PubMed ID: 10753717
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of active compounds against human respiratory syncytial virus.
Fu YH; Xu ZX; Jiang N; Zheng YP; Rameix-Welti MA; Jiao YY; Peng XL; Wang Y; Eleouet JF; Cen S; He JS
Virology; 2019 Sep; 535():171-178. PubMed ID: 31306912
[TBL] [Abstract][Full Text] [Related]
9. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.
Whelan JN; Tran KC; van Rossum DB; Teng MN
J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743
[TBL] [Abstract][Full Text] [Related]
10. Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen.
Duvall JR; VerPlank L; Ludeke B; McLeod SM; Lee MD; Vishwanathan K; Mulrooney CA; Le Quement S; Yu Q; Palmer MA; Fleming P; Fearns R; Foley MA; Scherer CA
Antiviral Res; 2016 Jul; 131():19-25. PubMed ID: 27059228
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-throughput replicon assay for the identification of respiratory syncytial virus inhibitors.
Tiong-Yip CL; Plant H; Sharpe P; Fan J; Rich K; Gorseth E; Yu Q
Antiviral Res; 2014 Jan; 101():75-81. PubMed ID: 24246168
[TBL] [Abstract][Full Text] [Related]
12. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
[TBL] [Abstract][Full Text] [Related]
13. Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway.
Wang S; Ling Y; Yao Y; Zheng G; Chen W
Virol J; 2020 Nov; 17(1):187. PubMed ID: 33239033
[TBL] [Abstract][Full Text] [Related]
14. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.
Laganas VA; Dunn EF; McLaughlin RE; Tiong-Yip CL; Yuzhakov O; Isabella VM; Hill P; Yu Q
Antiviral Res; 2015 Mar; 115():71-4. PubMed ID: 25542974
[TBL] [Abstract][Full Text] [Related]
17. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
18. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
McCutcheon KM; Jordan R; Mawhorter ME; Noton SL; Powers JG; Fearns R; Cihlar T; Perron M
J Virol; 2016 Feb; 90(4):1705-17. PubMed ID: 26608311
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness.
Lo MS; Brazas RM; Holtzman MJ
J Virol; 2005 Jul; 79(14):9315-9. PubMed ID: 15994826
[TBL] [Abstract][Full Text] [Related]
20. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
Paulus C; Krauss S; Nevels M
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
